Results 21 to 30 of about 4,386 (137)
Mifepristone alone versus mifepristone-misoprostol combination regimen for management of intrauterine fetal death [PDF]
, 2022 Background: Early pregnancy failure is a common complication of pregnancy. If women do not abort spontaneously, they will undergo medical or surgical treatment in order to remove the products of conception from the uterus.
Islam, Mohibul +4 more
core +1 more source
Synergistic lethality of mifepristone and LY294002 in ovarian cancer cells [PDF]
, 2013 We have previously shown that the antiprogestin and antiglucocorticoid mifepristone inhibits the growth of ovarian cancer cells. In this work, we hypothesized that cellular stress caused by mifepristone is limited to cytostasis and that cell killing is ...
Wempe, Stacy L. +2 more
core +1 more source
Clinical Update on Uses for Mifepristone in Obstetrics and Gynecology [PDF]
, 2022 Importance: Mifepristone (RU-486) is a selective progesterone receptor modulator that has antagonist properties on the uterus and cervix. Mifepristone is an effective abortifacient, prompting limitations on its use in many countries.
Bryant, Amy G. +2 more
core +1 more source
Optimized pharmacological control over the AAV-Gene-Switch vector for regulable gene therapy
Molecular Therapy: Methods & Clinical Development, 2021 Gene therapy in its current design is an irreversible process. It cannot be stopped in case of unwanted side effects, nor can expression levels of therapeutics be adjusted to individual patient’s needs.
Shi Cheng +4 more
doaj +1 more source
Advances in the management of uterine fibroids [PDF]
, 2009 Uterine fibroids are extremely common, with major surgery the current main management option; uterine artery embolisation is an alternative, but risks to fertility are unclear.
Munro, Kirsty I, Critchley, Hilary Od
core +1 more source
FACETS, 2020 In 2017, mifepristone and misoprostol became available for early pregnancy termination as the combination pack Mifegymiso® in Ottawa, Ontario, Canada.
Kathryn J. LaRoche +2 more
doaj +1 more source
Pakistan Journal of Pharmaceutical Sciences, 2022 To assess the clinical efficacy of mifepristone complicated with anemia and its effect on the hemoglobin, red blood cell, as well as hematocrit. Sixty patients with hysteromyoma complicated with anemia between December 2018 and December 2020 were ...
Renli Ye, China
doaj +1 more source
Mini-white[+] and mifepristone COX-PHA.
, 2023 Mating and receipt of male Sex Peptide hormone cause increased egg laying, increased midgut size and decreased life span in female Drosophila. Feeding mated females with the synthetic steroid mifepristone decreases egg production, reduces midgut size ...
Hanmei Bao (14952858) +8 more
core +1 more source
Fly, 2022 Mifepristone increases life span in female Drosophila melanogaster, and its molecular target(s) remain unclear. Here small molecule and genetic interventions were tested for ability to mimic mifepristone, or to decrease life span in a way that can be ...
Gary N. Landis +6 more
doaj +1 more source
Gynecological Endocrinology, 2023 Objective This study is aimed to determine the efficacy of a cocktail style treatment by combining GnRH-antagonist, letrozole, and mifepristone on the prevention of ovarian hyperstimulation syndrome (OHSS) in high-risk women.Methods This prospective ...
Qianrong Qi +4 more
doaj +1 more source